Fluorescence in Situ Hybridization Study of HER-2/neu Oncogene Amplification in Prostate Cancer

By Mark H.F.L.   Feldman D.   Das S.   Kye H.   Mark S.   Sun C.-L.   Samy M.  

Experimental and Molecular Pathology, Vol. 66, Iss. 2, 1999-06 ,pp. : 170-178

Elsevier

Access to resources Recommend Favorite

Trisomy 8 in Stage I and Stage III Ovarian Cancer Detected by Fluorescencein SituHybridization

By Mark H.F.L.   Afify A.M.   Werness B.A.   Das S.   Mark S.   Samy M.  

Experimental and Molecular Pathology, Vol. 66, Iss. 1, 1999-04 ,pp. : 76-81

Elsevier

Access to resources Recommend Favorite

Confrontation of immunohistochemistry and fluorescent in situ hybridization for the assessment of HER-2/ neu (c- erb b-2) status in urothelial carcinoma

By de Pinieux Gonzague  

Virchows Archiv, Vol. 444, Iss. 5, 2004-05 ,pp. : 415-419

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of outcomes between squamous cell carcinoma and adenocarcinoma in patients with surgically treated stage III cervical cancer

By                  

Molecular and Clinical Oncology, Vol. 2, Iss. 4, 2014-01 ,pp. : 518-524

Spandidos Publications

Access to resources Recommend Favorite

Laryngeal preservation in stage III/IV resectable laryngohypopharyngeal squamous cell carcinoma following concurrent chemoradiotherapy with capecitabine/cisplatin

By          

Molecular and Clinical Oncology, Vol. 1, Iss. 4, 2013-01 ,pp. : 685-691

Spandidos Publications

Access to resources Recommend Favorite